BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 33827756)

  • 21. Angiotensin Receptor Neprilysin Inhibitor in Japanese Patients With Heart Failure and Reduced Ejection Fraction - Baseline Characteristics and Treatment of PARALLEL-HF Trial.
    Tsutsui H; Momomura SI; Saito Y; Ito H; Yamamoto K; Ohishi T; Okino N; Kitamura T; Guo W
    Circ J; 2018 Sep; 82(10):2575-2583. PubMed ID: 30047502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials.
    Zannad F; Ferreira JP; Pocock SJ; Anker SD; Butler J; Filippatos G; Brueckmann M; Ofstad AP; Pfarr E; Jamal W; Packer M
    Lancet; 2020 Sep; 396(10254):819-829. PubMed ID: 32877652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gap between guidelines and clinical practice in heart failure with reduced ejection fraction: Results from TSOC-HFrEF registry.
    Chang HY; Wang CC; Wei J; Chang CY; Chuang YC; Huang CL; Chong E; Lin JL; Mar GY; Chan KC; Kuo JY; Wang JH; Chen ZC; Tseng WK; Cherng WJ; Yin WH
    J Chin Med Assoc; 2017 Dec; 80(12):750-757. PubMed ID: 29033112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Personalizing heart failure management in chronic kidney disease patients.
    Banerjee D; Wang AY
    Nephrol Dial Transplant; 2022 Oct; 37(11):2055-2062. PubMed ID: 33591313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator: The VICTORIA Trial.
    Armstrong PW; Roessig L; Patel MJ; Anstrom KJ; Butler J; Voors AA; Lam CSP; Ponikowski P; Temple T; Pieske B; Ezekowitz J; Hernandez AF; Koglin J; O'Connor CM
    JACC Heart Fail; 2018 Feb; 6(2):96-104. PubMed ID: 29032136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Heart Failure Knights.
    Mozzini C; Pagani M
    Curr Probl Cardiol; 2023 Sep; 48(9):101834. PubMed ID: 37244515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination Therapy of Renin Angiotensin System Inhibitors and β-Blockers in Patients with Heart Failure.
    Nochioka K; Sakata Y; Shimokawa H
    Adv Exp Med Biol; 2018; 1067():17-30. PubMed ID: 29542073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of current key guidelines for managing high-risk patients with diabetes and heart failure and future prospects.
    Lee MMY; Sattar N
    Diabetes Obes Metab; 2023 Jul; 25 Suppl 3():33-47. PubMed ID: 37041663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities.
    Albert NM; Tyson RJ; Hill CL; DeVore AD; Spertus JA; Duffy C; Butler J; Patterson JH; Hernandez AF; Williams FB; Thomas L; Fonarow GC
    Am Heart J; 2021 May; 235():82-96. PubMed ID: 33497697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation - Results from the German EuroAspire IV cohort.
    Morbach C; Wagner M; Güntner S; Malsch C; Oezkur M; Wood D; Kotseva K; Leyh R; Ertl G; Karmann W; Heuschmann PU; Störk S
    BMC Cardiovasc Disord; 2017 May; 17(1):108. PubMed ID: 28476146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin receptor-neprilysin inhibitors: A new paradigm in heart failure with reduced ejection fraction.
    Docherty KF; McMurray JJV
    Int J Cardiol; 2019 Apr; 281():179-185. PubMed ID: 29891240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF Registry.
    Vaduganathan M; Fonarow GC; Greene SJ; DeVore AD; Kavati A; Sikirica S; Albert NM; Duffy CI; Hill CL; Patterson JH; Spertus JA; Thomas LE; Williams FB; Hernandez AF; Butler J
    JACC Heart Fail; 2020 Jun; 8(6):469-480. PubMed ID: 32387066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence-Based Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease.
    Beldhuis IE; Lam CSP; Testani JM; Voors AA; Van Spall HGC; Ter Maaten JM; Damman K
    Circulation; 2022 Mar; 145(9):693-712. PubMed ID: 35226558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin receptor/neprilysin inhibitor-a breakthrough in chronic heart failure therapy: summary of subanalysis on PARADIGM-HF trial findings.
    Książczyk M; Lelonek M
    Heart Fail Rev; 2020 May; 25(3):393-402. PubMed ID: 31713710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient Eligibility for Established and Novel Guideline-Directed Medical Therapies After Acute Heart Failure Hospitalization.
    Moghaddam N; Hawkins NM; McKelvie R; Poon S; Joncas SX; MacFadyen J; Honos G; Wang J; Rojas-Fernandez C; Kok M; Sidhu V; Zieroth S; Virani SA
    JACC Heart Fail; 2023 May; 11(5):596-606. PubMed ID: 36732099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contemporary Pharmacologic Management of Heart Failure with Reduced Ejection Fraction: A Review.
    Egbuche O; Hanna B; Onuorah I; Uko E; Taha Y; Ghali JK; Onwuanyi A
    Curr Cardiol Rev; 2020; 16(1):55-64. PubMed ID: 31288726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A year in heart failure: an update of recent findings.
    Stretti L; Zippo D; Coats AJS; Anker MS; von Haehling S; Metra M; Tomasoni D
    ESC Heart Fail; 2021 Dec; 8(6):4370-4393. PubMed ID: 34918477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients.
    Cautela J; Tartiere JM; Cohen-Solal A; Bellemain-Appaix A; Theron A; Tibi T; Januzzi JL; Roubille F; Girerd N
    Eur J Heart Fail; 2020 Aug; 22(8):1357-1365. PubMed ID: 32353213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New pharmacological treatments for heart failure with reduced ejection fraction (HFrEF): A Bayesian network meta-analysis.
    Li H; Duan Y; Chen B; Zhao Y; Su W; Wang S; Wu J; Lu L
    Medicine (Baltimore); 2020 Jan; 99(5):e18341. PubMed ID: 32000355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure With Reduced Ejection Fraction Patients.
    Srivastava PK; DeVore AD; Hellkamp AS; Thomas L; Albert NM; Butler J; Patterson JH; Spertus JA; Williams FB; Duffy CI; Hernandez AF; Fonarow GC
    JACC Heart Fail; 2021 Jan; 9(1):28-38. PubMed ID: 33309579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.